Formulation of Vernonia amygdalina and Calotropis procera leaf extracts into a cream for the management of skin infections
Main Article Content
Abstract
Background: The incidence of skin infections in West Africa and in fact globally continues to increase at an alarming rate.
Objective: This study was carried out to formulate the methanol extracts from Vernonia amygdalina and Calotropis procera into a topical cream for the treatment and management of skin infections.
Methods: Each extract was tested and thereafter combined in ratios 0:1, 1:3, 1:1, 3:1 and 1:0 Vernonia: Calotropis (V:C). The best extract combination based on results of zones of inhibition was then formulated into modified aqueous, cetomacrogol and vanishing cream bases. The creams were formulated at an extract concentration of 2.5, 5 and 10% w/w in the bases. The creams were further assessed for their physical and chemical properties. Antimicrobial activities of the creams were examined by the agar well diffusion method against Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, and Trichophyton rubrum. A combination of ketoconazole and neomycin was used as control.
Results: The creams exhibited zones of inhibition ranging from 8.00 ± 0.54 to 30.00 ± 0.00 mm. The extracts combined in ratio 3:1 V:C yielded the highest zones of inhibition ordinarily and in the cream across the test organisms. The cetomacrogol base was incompatible with the extract combinations, therefore unstable; the modified Aqueous cream base was stable with no antimicrobial activity while the vanishing cream base gave a stable cream with zones of inhibition against the test organisms.
Conclusion: These outcomes confirm that these extracts possess antimicrobial activities, and when incorporated into creams, their activities vary according to the cream bases employed with the vanishing cream base being the most effective.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Nahida T, Mariya H (2014). Plants used to treat skin diseases. Pharmacognosy Reviews 8(15): 52–60.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Naghavi M (2014). The Global burden of skin disease in 2010?: An analysis of the prevalence and impact of skin conditions. Journal of Investigative Dermatology 134(6): 1527–1534.
Scholfield J, Grindlay D, Williams H. Skin conditions in the UK: A health needs assessment. Metro Commercial Printing Limited: Hertfordshire, UK, 2009: 9-23
Basra M, Shahrukh M (2009). Burden of skin diseases. Expert Reviews in Pharmacoeconomics Outcomes, 9: 271–83.
Adebola OO (2004). Prevalence of skin diseases in Ibadan, Nigeria. International Journal of Dermatology 43: 31–36.
Ghebremedhin B, Olugbosi M, Raji A, Layer F, Bakare R, König B, König W (2009). Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. Journal of Clinical Microbiology 47(9): 2975–2980.
Verma S, Singh S (2008). Current and future status of herbal medicines. Veterinary World 1(11): 347–350.
Neenah E, Ahmed M (2011). Anti-microbial activity of extracts and latex of Calotropis procera and synergistic effect with reference to antimicrobials. Research Journal of Medicinal Plants 5(6): 706–716.
Bonjar GH, Farrokhi PR (2004). Antibacillus activity of some plant used in traditional medicine of Iran. Nigerian Journal on Natural Product Medicines (8): 34–39.
Audu SA, Alemika ET, Abdulraheem RO, Abdulkareem SS, Abdulraheem RB, Ilyas M (2012). A Study review of documented phytochemistry of Vernonia amygdalina (Family Asteraceae ) as the basis for pharmacologic activity of plant extract. Journal of Natural Sciences Research 2(7): 1–9.
Imaga NOA, Bamigbetan DO (2013). In vivo biochemical assessment of aqueous extracts of Vernonia amygdalina (Bitter leaf). International Journal of Nutritional Metabolisms 5(February):22–27.
Oboh FOJ, Enobhayisobo EI (2009). Effect of aqueous extract of leaves on plasma lipids Vernonia amygdalina of hyperlipidaemic adult
male albino New Zealand rabbits. African Scientist10(4).
Irvine FR. Woody plants of Ghana. Oxford University Press, London, 1961: 48-50.
Asolkar L, Kakkar K, Chakra O (1992). Second supplement to glossary of Indian medicinal plants with active principles. Public & Infantry Division (CSIR) New Delhi (17): 414.
Nadkarni AK, Nadkarni KM. Indian material medica. Popular Book Depot, Bombay, 1960: 69-71.
Mehta, R. Topical and Transdermal Drug Delivery?: What a Pharmacist Needs to Know, 2004: (221), 1 – 1 0 . R e t r i e v e d f r o m
Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, Yacobi A (2009). Topical and transdermal drug products. Pharmacopeial Forum 35(3): 750–764.
Ponen S. Cetomacrogol cream, 2016. Retrieved fromhttp://www.healthnavigator.org.nz/medicines/c/cetomacrogol-cream/
Joint Formulary Committee. British National Formulary (BNF), 57 edition. Pharmaceutical Press, UK, 2009. Retrieved from www.bnf.org.
Juhaeni, R. N. Formulation and Evaluation of Various Cosmetic and Dental. PHARMAQUEST, 2010. Retrieved from
http://pharmaquest.weebly.com/uploads/9/9/4/2/9942916/formulation__evaluation_of_cosmetic_pdts.pd
Adebayo MA, Aboaba SA, Eresanya OI, Ajetunmobi AA, Ogunwande IA (2015). Constituent of essential oil from Ficus benghalensis L . European Journal of Medicinal Plants 9(2): 1–6.
Russel A, Furr J (1977). The antibacterial activity of a new chloroxylenol preparation containing ethylenediamine tetraacetic acid. Journal of
Applied Bacteriology 43: 253.
British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary (68th ed.), UK: BMJ Publishing
Group, 2014.
Ofori-Kwakye K, Kwapong AA, Adu F (2009). Antimicrobial activity of extracts and topical products of the stem bark of Spathodea
campanulata for wound healing. African Journal of Traditional, Complementary and Alternative Medicine 6(2): 168–174.
Stephen OM, Akanimo AE (2012). Development and evaluation of antimicrobial herbal formulations containing the methanolic extract of Cassia alata for skin diseases. Journal of Advanced Pharmaceutical Technology & Research 3(2): 106–11.
Kola-Mustapha AT, Ghazali YO & Iranloye TA (2016). Antimicrobial Screening of the combination of Vernonia amygdalina and Calotropis procera methanol leaf extracts. Journal of Pharmaceutical Research Development and Practice 1(1): 25-33.
Kola-Mustapha A, Aremu O, Njiga N, Ayotunde H (2014). Antifungal screening of Ceiba petandra and Lannea kerstingii stem bark extract cream formulations. The Journal of Pharmaceutical Sciences and Pharmacy Practice 10(4): 227–232.
Kamboj VP (2000). Herbal medicine. Current Science 78(1): 35–51.
Eyo JE, Nwachukwu LO, Onah IE, Atama CI, Ekeh FN, Ngozi EE, Njoku I (2013). Effects of the aqueous root extract of Vernonia amygdalina on the haematological profile of Rattus norvegicus. Advances in Life Science and Technology 11(1986): 19–24.
Manoorkar VB, Mandge SV, Gachande BD (2015). Antifungal activity of leaf and latex extracts of Calotropis procera (Ait) against dominant seedborne storage fungi of some oil seeds. Bioscience Discovery 6(1): 22–26.
British Pharmaceutical Codex. British Pharmaceutical Codex (11th Edition). London Pharmaceutical Press: London 1979.
Labib GS, Aldawsari H (2015). Innovation of natural essential oil-loaded Orabase for local treatment of oral candidiasis. Drug Design, Development and Therapy 9:3349-3359.
Eraga S, Arhewoh M, Ivuongbe F, Eze H (2015). Some physical properties of Vernonia amygdalina and Garcinia kola microspheres prepared with high molecular weight polyethylene glycols. Journal of Applied Science and Environmental Management 19(1): 29–34.
Kareem SO, Akpan I, Ojo OP (2008). Antimicrobial activities of Calotropis procera on selected pathogenic microorganisms. African Journal of Biomedical Research 11(September 2007): 105–110.
Dhase AS, Khadbadi SS, Saboo SS (2014). Formulation and evaluation of vanishing herbal cream of crude drugs. American Journal of
Ethnomedicine 1(5): 313–318.
Schmid-Wendtner MH, Korting HC (2006). The pH of the skin surface and its impact on the barrier function. Skin Pharmacology and Physiology 19(10): 296–302.